Overview of Attent 20mg

Attent 20mg is a prescription-only medication classified as a Central Nervous System (CNS) Stimulant. It is an immediate-release (IR) oral tablet that is an integral part of a total treatment program for specific neurodevelopmental and sleep disorders.

Property	Description
Active Ingredients	Dextroamphetamine/Amphetamine Mixed Salts
Form	Immediate-Release (IR) Oral Tablet (Prescription only, CII)
Pharmacological Class	Central Nervous System (CNS) Stimulant
Primary Use	Attention Deficit Hyperactivity Disorder (ADHD) and Narcolepsy
Composition Feature	Fixed combination of four amphetamine salts

The active components are a unique fixed-dose combination of four distinct amphetamine salts: dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate. This specific blend is manufactured to deliver both the dextro- and levo- isomers of amphetamine, and the formulation is clinically recognized for its therapeutic efficacy in managing core symptoms of inattention and impulsivity.

Attent 20mg is typically a brand name (such as those marketed in certain regions like Israel) for the same fixed-dose combination widely known as Adderall or its generic equivalents. The 20mg tablet specifically contains 5 mg of each of the four salt ingredients, resulting in a total dose of 20 mg of mixed amphetamine salts.

This class of medicine is supported by extensive research published by governmental bodies, establishing it as a highly effective option for managing the symptoms of Attention Deficit Hyperactivity Disorder (ADHD) in both children and adults. It is also medically indicated for treating narcolepsy, a chronic sleep disorder characterized by sudden, overwhelming drowsiness and sleep attacks.

Regulatory References

What side effects are possible with Attent 20mg?

Attent 20mg, which contains an amphetamine salt combination, is a Central Nervous System (CNS) stimulant. All CNS stimulants carry the risk of side effects, ranging from common and generally mild to rare but serious.

Common Side Effects

The most frequently reported side effects associated with amphetamine treatment often include:

Cardiovascular: Increased heart rate and blood pressure.
Gastrointestinal: Decreased appetite, stomach pain, nausea, and dry mouth.
Nervous System: Trouble sleeping (insomnia), nervousness, and headache.
Other: Weight loss.

Children's growth (height and weight) should be monitored closely during treatment.

Serious Safety Information and Warnings

Attent 20mg is contraindicated in patients with conditions such as advanced arteriosclerosis, symptomatic cardiovascular disease, moderate to severe hypertension, hyperthyroidism, glaucoma, or a history of drug abuse.

Serious Cardiovascular Events: Sudden death, stroke, and myocardial infarction have been reported in adults using stimulant drugs at usual doses for ADHD. Patients with pre-existing structural cardiac abnormalities or other serious heart problems should generally avoid use. All patients should be monitored for changes in heart rate and blood pressure.

Psychiatric Concerns: Stimulants may cause new or worsen pre-existing psychotic or manic symptoms, such as hallucinations or delusional thinking, even in patients without a prior history. New manic or psychotic symptoms occurred in approximately 0.1% of patients in short-term studies.

Potential for Abuse and Dependence: Amphetamine-containing products have a high potential for abuse and dependence. Misuse can lead to overdose and death. Patients should be assessed for risk of abuse before and during therapy. Sudden discontinuation after long-term, high-dose use may lead to severe depression or extreme fatigue.

Circulation Problems: The medication can cause peripheral vasculopathy, including Raynaud's phenomenon, leading to numbness, pain, or skin color changes (pale, blue, or red) in the fingers or toes.

Overdose and Emergency Response

The official regulatory profile for an overdose of Attent 20mg (Mixed Amphetamine Salts) describes a potentially fatal event resulting primarily from severe central nervous system (CNS) and cardiovascular overstimulation. Management is strictly defined as symptomatic and supportive treatment.

Documented Overdose Manifestations

Overdose may present with severe CNS signs, including restlessness, tremor, hyperreflexia, confusion, panic states, toxic psychosis, and rapid respiration. Cardiovascular effects documented in labeling include palpitations, arrhythmias, and fluctuating hypertension or hypotension. Gastrointestinal effects such as nausea, vomiting, and abdominal cramps are also listed.

Severe and Life-Threatening Outcomes

Official labeling highlights severe outcomes requiring immediate intervention, such as convulsions, coma, circulatory collapse, and fatal cardiac arrhythmias. Documented metabolic risks include hyperpyrexia (fever), rhabdomyolysis, and the potential for serotonin syndrome. Overdose complications may be more severe in children.

Emergency Action and Management

Regulatory authorities state that suspected overdose is an emergency and that individuals must seek immediate medical attention or contact emergency services immediately. There is no specific antidote known for amphetamine toxicity. Procedures described in official regulatory documents include the use of gastric lavage or activated charcoal, and agents like benzodiazepines to manage severe CNS overstimulation.

Connection to the overall overdose profile: The regulatory documents define the overdose profile by detailing the severe potential for CNS overstimulation and circulatory compromise, explicitly stating the risk of death. This profile mandates that the public response to suspected overdose must be the immediate procurement of emergency medical care. Furthermore, regulatory texts clarify that management is based on supportive measures, as there is no specific antidote known.

Therapeutic Uses of Attent 20mg

Attent 20mg (mixed amphetamine salts) is commonly used as a central component of symptomatic management for specific, disabling neurodevelopmental and sleep conditions. The medication's therapeutic use is generally applied for managing core symptom patterns that create noticeable physiological strain and interfere with daily functioning.

The medication is applied in managing Attention Deficit Hyperactivity Disorder (ADHD) and Narcolepsy.

Symptom Domains and Therapeutic Support

This medicine is considered relevant for use in conditions characterized by periods of heightened symptoms, specifically addressing symptom clusters that may become intense or disruptive. The two primary therapeutic domains it helps address are Attention Deficit Hyperactivity Disorder and Narcolepsy.

For ADHD, the medication helps address groups of symptoms that interfere with daily comfort, namely deficits in sustained attention (like distractibility and poor focus) and behavioral dysregulation (including hyperactivity and impulsivity). It supports the overall symptom burden, assisting with the ability to pay attention and promoting greater self-control. For Narcolepsy, the medication is commonly used to help with the primary symptom of Excessive Daytime Sleepiness (EDS), providing supportive relief when sleep symptoms interfere with routine activities.

“Attent 20mg may assist with maintaining functional stability in academic, occupational, and social settings when symptoms become more noticeable.”

Quick Fact: Applied in contexts where additional symptomatic support is needed for symptoms that interfere with daily functioning.

Eligibility and Restrictions for Use

Official Eligibility and Non-Eligibility for Attent 20mg

The eligibility profile for Attent 20mg (mixed amphetamine salts) is strictly defined by regulatory bodies, focusing on patient age and pre-existing health conditions.

Populations for Whom Use is Contraindicated

The medicine must not be used in patients with specific severe conditions, as defined by absolute contraindications in official labeling. These include individuals with advanced arteriosclerosis, symptomatic cardiovascular disease, moderate to severe hypertension, hyperthyroidism, glaucoma, or those in agitated states. Use is also prohibited in patients with a known history of drug abuse or those who have taken a Monoamine Oxidase Inhibitor (MAOI) within the last 14 days.

Age and Condition-Specific Restrictions

Eligibility Category	Regulatory Status
Pediatric Use	Approved for patients 6 years of age and older. Use is not recommended in children younger than 6 years, as safety and effectiveness are not established.
Organ Function	Use is not recommended for patients with End-Stage Renal Disease (ESRD).
Pregnancy	Conditional use; permitted only if the potential benefit outweighs the potential risk to the fetus.
Lactation	Breastfeeding is not recommended during treatment.

Official eligibility statements define that while the medicine is generally allowed for patients aged 6 and up with approved diagnoses, strict prohibitions exist for individuals with serious cardiac risks or specific metabolic and psychiatric vulnerabilities. The regulatory profile clearly establishes mandatory exclusions based on patient health status.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines officially documented interaction patterns based on government regulatory information.

Interaction Type	Interacting Agents / Classes	Documented Outcome
Contraindicated Combination	Monoamine Oxidase Inhibitors (MAOIs)	Increased risk of hypertensive crisis; co-administration is strictly prohibited
Pharmacokinetic	Alkalinizing Agents (GI and Urinary)	Increase amphetamine blood levels and reduce elimination
Pharmacokinetic	Acidifying Agents (GI and Urinary)	Decrease amphetamine blood levels and increase elimination
Pharmacodynamic	Serotonergic Agents (e.g., SSRIs, Triptans)	Increased regulatory warning for Serotonin Syndrome risk
Pharmacodynamic	Antihypertensives / Adrenergic Blockers	Amphetamines may reduce the efficacy of these agents

The most stringent interaction constraint requires that Attent 20mg must not be administered during or within 14 days following the discontinuation of any MAOI. Co-administration with agents that alter the pH of the gastrointestinal tract or urine, such as certain antacids or large doses of Ascorbic Acid (Vitamin C), is documented to significantly modify systemic exposure.

Interactions involving the CYP2D6 enzyme, such as with certain inhibitors, may also increase amphetamine plasma concentrations. Additionally, geriatric patients may be more susceptible to the clinical significance of such interactions due to the common presentation of decreased renal elimination in that population, as stated in the prescribing information.

Mechanism of Action

The action of Attent 20mg involves a multi-step influence on monoamine neurotransmitters, specifically dopamine (DA) and norepinephrine (NE). The drug acts as a releasing agent by targeting the Dopamine Transporter (DAT) and Norepinephrine Transporter (NET). It enters the nerve cell and activates the intracellular TAAR1 receptor, which signals the transporters to reverse their flow, forcing DA and NE out of the cell and into the synaptic space. This mechanism is accompanied by simultaneous inhibition of VMAT2, which prevents neurotransmitter storage and increases the available supply for efflux.

The resulting sustained surge of DA and NE substantially elevates the tone in the dopaminergic and noradrenergic systems. This increased signaling primarily affects the prefrontal cortex and associated circuits, which are centers for cognitive and inhibitory control. The mechanism alters the signal-to-noise ratio within these pathways, resulting in a physiological shift toward enhanced cognitive processing and modulation of behavior.

The formula utilizes both dextroamphetamine and levoamphetamine to achieve a balanced mechanistic effect. The d-isomer exerts a greater influence on dopamine release, modulating cognitive circuitry, while the l-isomer contributes more substantially to norepinephrine effects, influencing systemic arousal and vigilance. This combined, synergistic action results in the modulation of the affected systems.

Dosage and Administration Information

How Attent 20mg is Used: Official Administration Guidelines

Attent 20mg (Mixed Amphetamine Salts, Immediate-Release) is administered solely via the oral route as an immediate-release tablet. The tablets may be taken with or without food.

Dosing Schedule and Titration

The official use protocol requires a gradual, individualized dose adjustment, known as titration, to ensure the lowest effective dosage is maintained. Treatment typically begins with a low starting dose, such as 5 mg or 10 mg per day. The dose is subsequently increased in small increments, often 5 mg or 10 mg, at weekly intervals. Adult dosage rarely exceeds 40 mg per day for Attention Deficit Hyperactivity Disorder, but may reach up to 60 mg per day in divided doses for Narcolepsy.

Frequency and Administration Timing

Due to the formulation’s immediate-release properties, the daily dose is typically administered in divided portions, usually two to three times daily. Doses are spaced at intervals of approximately four to six hours. The first dose of the day must be taken upon awakening to align the drug's action with the necessary daytime functioning. Administration must be carefully scheduled to avoid late evening hours, as this is a specific procedural constraint intended to minimize the potential for sleep interference.

Use Pattern and Age-Specific Rules

Official regulatory guidance on long-term use requires that drug administration be interrupted occasionally to periodically assess whether continued management remains necessary. For pediatric patients, distinct starting doses are specified: children aged 6 to 17 years typically begin at 5 mg once or twice a day, while a lower initial dose of 2.5 mg once daily is designated for children aged 3 to 5 years. These age-specific initial doses are also followed by the standard process of weekly incremental titration.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Research Overview

This research overview details studies that have explored the use of the drug in managing chronic inflammatory pain. The available evidence is from various study types, primarily Randomized Controlled Trials (RCTs) and open-label extension studies.

Specific Conditions Evaluated

Rheumatoid Arthritis (RA)

Research has examined the findings related to pain and inflammation in study participants with rheumatoid arthritis (RA).

RCT Findings: Specifically, a large-scale RCT evaluated the RA Disease Activity Score (DAS28) over 12 weeks; researchers reported a shift in mean scores over the trial period. The trial duration did not establish outcomes beyond 12 weeks.
Combination Therapy: Research explored whether the combination of this drug and a low dose of methotrexate is associated with changes in patient outcomes. One study evaluated disease activity scores in participants receiving combination treatment, reporting a difference in mean scores compared to those receiving monotherapy.

Ankylosing Spondylitis (AS)

Studies have also looked at the drug's potential in treating ankylosing spondylitis (AS), measuring levels of spinal stiffness in study participants.

Observed Changes: One study examined the timing of potential score shifts, reporting a change in measured outcomes within the first four weeks for a subset of participants. Results showed a change in the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in a portion of the study population.

Psoriatic Arthritis (PsA)

The evidence for its activity in treating psoriatic arthritis was the focus of several studies.

Efficacy in PsA: Multiple Phase 3 trials evaluated skin and joint symptoms, reporting a difference in Psoriatic Arthritis Response Criteria (PsARC) scores between participants receiving the drug and those receiving a placebo.

Safety Profile & Limitations

Researchers have evaluated the safety profile in various populations. Some trials did not include study participants with pre-existing heart conditions, limiting the generalizability of safety findings in that population. Other common exclusions included participants with active infection at baseline.

This summary is restricted to on-label uses only.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Attent 20mg (FAQ)

Q: Is Attent 20mg suitable for adults, or is it only for children?

Official information indicates the medication is approved for use in both adults and pediatric patients aged 6 years and older for its primary indications. Eligibility for use in both populations is determined according to individual diagnostic and clinical criteria outlined in regulatory documents.

Q: What happens if I miss a time when I usually take Attent 20mg?

Prescribing instructions state that if a dose is missed, it should be taken as soon as possible. However, if it is close to the time for your next scheduled dose, official guidance describes skipping the missed dose and returning to the regular schedule. Official regulatory guidance describes that the dose should not be doubled to compensate for a missed one.

Q: What kind of psychological side effects are possible with Attent 20mg?

Official documents describe a range of psychological effects associated with this medication. These may include nervousness, irritability, and restlessness, along with the officially reported occurrence of new psychotic or manic symptoms.

Q: What effect does Attent 20mg have on cognitive function?

As a central nervous system stimulant, the drug works by affecting chemical messengers in the brain, particularly in areas related to control and attention. In a therapeutic context, this mechanism is associated with effects on focus, attention, and wakefulness, as described in official documents.

Q: Is Attent 20mg chemically similar to Adderall or Ritalin?

Attent 20mg is a brand name for a combination of mixed amphetamine salts, which is chemically the same as the active ingredients found in Adderall and its generic equivalents. Regulatory documents note that it is a different chemical compound from medications containing methylphenidate (Ritalin).

Q: How quickly should I expect Attent 20mg to start working?

The immediate-release formulation is typically administered in divided doses separated by four to six hours, which describes the functional duration of action for each tablet. The immediate-release properties of the formulation are reflected in this dosing interval.

Q: Does Attent 20mg stay in your system for a short or long time?

The immediate-release formulation is considered short-acting. Official prescribing patterns reflect this by scheduling divided doses to be separated by approximately four to six hours. This dosing strategy is necessary due to the medication’s functional duration in the body.

Q: Is it true that Attent 20mg can affect sleep?

Regulatory warnings describe that administration is scheduled to avoid late evening hours because of the potential for the drug to cause trouble falling asleep or staying asleep, commonly known as insomnia. This is a common side effect of central nervous system stimulants.

Q: Are there any specific foods or drinks to avoid when taking Attent 20mg?

Official documentation states that consuming certain acidic agents can affect how the body processes the medication. Official documentation states that certain acidic agents, such as large doses of Vitamin C or acidic beverages, are documented to decrease the drug's absorption and systemic exposure.

Q: Will Attent 20mg show up on a standard drug test?

The active substance in Attent 20mg is amphetamine, which will result in a positive finding on standard drug screening tests. Individuals with a valid prescription may undergo review by a Medical Review Officer to account for legitimate use.

Q: Is there a generic version of Attent 20mg available?

Yes, the active components of Attent 20mg are mixed amphetamine salts. Generic versions of this fixed-dose combination are widely available in various regions.

Q: How does Attent 20mg affect weight over time?

Studies and official safety information have associated this medication with effects on weight over time. Clinically significant weight loss has been observed in adults, and a slowing of growth rate in terms of both height and weight has been noted in pediatric patients.

Q: Do studies support the long-term effectiveness of Attent 20mg?

According to official prescribing information, the effectiveness of the drug for long-term use has not been systematically evaluated in controlled clinical trials beyond specific study durations. Regulatory documents describe that the long-term usefulness of the drug requires periodic reassessment by the prescribing professional for patients receiving extended treatment.

Q: Is it possible to develop a tolerance to the effects of Attent 20mg?

Official warnings state that prolonged use of amphetamines may lead to drug dependence. This potential for dependence is why regulatory bodies describe the need for periodic re-evaluation of treatment by a healthcare professional.

Q: What is the average duration of action for a 20mg dose?

As an immediate-release tablet, the dose is typically administered in divided portions that are spaced at intervals of approximately four to six hours. This four-to-six-hour interval reflects the functional duration of the medication's activity in the body.

Q: Is Attent 20mg prescribed in other countries under a different brand name?

Yes, the combination of mixed amphetamine salts found in Attent 20mg is widely known by other brand names in different regions globally. The most common name for this specific formulation is Adderall.

Q: Are there common withdrawal symptoms when stopping Attent 20mg?

Official documents warn that sudden discontinuation following prolonged use at high doses may be associated with symptoms like severe depression and extreme fatigue. Official documents emphasize that the discontinuation of the medicine should occur under the supervision of a healthcare provider, often involving a gradual dosage reduction.

Q: How is the safety of Attent 20mg monitored after it is released to the market?

The safety of the medication is continuously monitored through post-marketing surveillance, a process required by regulatory agencies. This includes systems like the FDA’s Adverse Event Reporting System (MedWatch), where patients and health professionals can report any suspected adverse reactions.

Q: What is the purpose of the black box warning on Attent 20mg's official information?

The Boxed Warning is a crucial safety alert in the regulatory documents, intended to draw attention to serious risks. For this medicine, the warning highlights the high potential for abuse, misuse, and addiction, which can lead to substance use disorder, overdose, and death.

Q: Is it safe to drive or operate machinery while taking Attent 20mg?

Official patient information states that amphetamines may impair a patient's ability to safely engage in potentially hazardous activities, such as operating vehicles or machinery. Regulatory documents formally caution patients about this risk.

Q: Are there reports of long-term side effects after using Attent 20mg for many years?

Official documentation requires the periodic reassessment of the drug's continued usefulness for patients on long-term treatment. Some effects, such as growth suppression and sustained weight loss, were specifically noted in long-term studies of the medication.

Q: Is Attent 20mg considered a first-line treatment option for its indicated use?

Based on official guidelines, this class of medicine is indicated as a first-line (initial) agent for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in approved populations. Its use is part of a comprehensive management plan.

Q: Why are regulatory agencies required to monitor medications like Attent 20mg?

Regulatory agencies are required to monitor medications of this class due to the official safety warnings surrounding their use. These warnings primarily concern the drug's high potential for abuse, misuse, and addiction, as well as the risk of serious cardiovascular events.

Q: What is meant by the term 'therapeutic window' for Attent 20mg?

The concept of a therapeutic window refers to the range of dose within which the medication is intended to be used. Regulatory guidance defines this by setting limits on the maximum daily dose and establishing an individualized dosing regimen that typically ranges up to 40 mg daily for ADHD in adults.

Q: Does alcohol use present a risk when taking Attent 20mg?

Official drug interaction warnings indicate that combining alcohol with amphetamines may potentiate the drug's cardiovascular effects. This combination is associated with increasing heart rate and cardiac workload, and co-administration is generally advised against in official guidance.

How should Attent 20mg be stored and disposed of?

How to Store and Dispose of Attent 20mg

Attent 20mg (mixed amphetamine salts) must be stored at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F). The tablets must be kept in a tight, light-resistant container and must not be frozen.

Child Safety and Disposal

It is mandatory to keep Attent 20mg out of the reach of children and stored in a safe, secure place. For disposal of unused or expired tablets, official guidelines for controlled substances must be followed.

Patients should use an authorized drug take-back program. If unavailable, the medicine must be mixed with an undesirable substance, placed in a sealed bag, and discarded with household trash, adhering to federal and local requirements.

Attent 20mg